Abstract
[Extract] Although the covid-19 pandemic has provoked the best of human compassion, the hallmarks of unhealthy commercial influence have also emerged. This week, The BMJ published the initial list of signatories to our call for action to reduce commercial influence in how healthcare evidence is produced and used (www.bmj.com/commercial-influence-call-to-action). Signatories include professors, patient advocates, clinicians, and researchers who want to see product evaluation, medical education, and clinical practice much freer from commercial interests.
Original language | English |
---|---|
Article number | m2456 |
Number of pages | 2 |
Journal | BMJ (Clinical research ed.) |
Volume | 369 |
DOIs | |
Publication status | Published - 24 Jun 2020 |